FDA Proposes Coal Tar/Menthol Addition To OTC Dandruff Monograph

The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products would be amended to include a specific combination of coal tar and menthol under a proposed rule published by FDA in the Federal Register Dec. 9

More from Archive

More from HBW Insight